{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T22:36:46Z","timestamp":1791067006254,"version":"4.1.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,1,3]],"date-time":"2014-01-03T00:00:00Z","timestamp":1388707200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1007\/s00432-013-1577-z","type":"journal-article","created":{"date-parts":[[2014,1,2]],"date-time":"2014-01-02T09:55:54Z","timestamp":1388656554000},"page":"387-397","source":"Crossref","is-referenced-by-count":65,"title":["miR-145 functions as tumor suppressor and targets two oncogenes, ANGPT2 and NEDD9, in renal cell carcinoma"],"prefix":"10.1007","volume":"140","author":[{"given":"Ruijing","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziliang","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingna","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunjuan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhimao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiqiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhendong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,1,3]]},"reference":[{"issue":"12","key":"1577_CR1","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1038\/sj.bjc.6603796","volume":"96","author":"M Baldewijns","year":"2007","unstructured":"Baldewijns M, Thijssen V, Van den Eynden G, Van Laere S, Bluekens A, Roskams T, Van Poppel H, De Bruine A, Griffioen A, Vermeulen P (2007) High-grade clear cell renal cell carcinoma has a higher angiogenic activity than low-grade renal cell carcinoma based on histomorphological quantification and qRT\u2013PCR mRNA expression profile. Br J Cancer 96(12):1888\u20131895","journal-title":"Br J Cancer"},{"issue":"1","key":"1577_CR2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cell.2004.12.031","volume":"120","author":"E Berezikov","year":"2005","unstructured":"Berezikov E, Guryev V, van de Belt J, Wienholds E, Plasterk RH, Cuppen E (2005) Phylogenetic shadowing and computational identification of human micro RNA genes. Cell 120(1):21\u201324","journal-title":"Cell"},{"key":"1577_CR3","doi-asserted-by":"crossref","first-page":"4630","DOI":"10.1200\/JCO.2010.28.3945","volume":"28","author":"A Bullock","year":"2010","unstructured":"Bullock A, Zhang L, O\u2019Neill A, Percy A, Sukhatme V, Mier J, Atkins M, Bhatt R (2010) Plasma angiopoietin-2 (ANG2) as an angiogenic biomarker in renal cell carcinoma (RCC). J Clin Oncol 2010(28):4630","journal-title":"J Clin Oncol"},{"issue":"12","key":"1577_CR4","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1038\/nrc2967","volume":"10","author":"S Cabodi","year":"2010","unstructured":"Cabodi S, del Pilar Camacho-Leal M, Di Stefano P, Defilippi P (2010) Integrin signalling adaptors: not only figurants in the cancer story. Nat Rev Cancer 10(12):858\u2013870","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"1577_CR5","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1007\/s12032-012-0213-0","volume":"29","author":"J-X Chang","year":"2012","unstructured":"Chang J-X, Gao F, Zhao G-Q, Zhang G-J (2012) Expression and clinical significance of NEDD9 in lung tissues. Med Oncol 29(4):2654\u20132660","journal-title":"Med Oncol"},{"key":"1577_CR6","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/1479-5876-10-228","volume":"10","author":"B Chen","year":"2012","unstructured":"Chen B, Li H, Zeng X, Yang P, Liu X, Zhao X, Liang S (2012) Roles of microRNA on cancer cell metabolism. J Transl Med 10:228. doi: 10.1186\/1479-5876-10-228","journal-title":"J Transl Med"},{"issue":"5","key":"1577_CR7","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/sj.bjc.6605570","volume":"102","author":"T Chiyomaru","year":"2010","unstructured":"Chiyomaru T, Enokida H, Tatarano S, Kawahara K, Uchida Y, Nishiyama K, Fujimura L, Kikkawa N, Seki N, Nakagawa M (2010) miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer. Br J Cancer 102(5):883\u2013891","journal-title":"Br J Cancer"},{"issue":"23","key":"1577_CR8","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1056\/NEJMra043172","volume":"353","author":"HT Cohen","year":"2005","unstructured":"Cohen HT, McGovern FJ (2005) Renal-cell carcinoma. New Engl J Med 353(23):2477\u20132490","journal-title":"New Engl J Med"},{"issue":"5","key":"1577_CR9","first-page":"2145","volume":"61","author":"T Etoh","year":"2001","unstructured":"Etoh T, Inoue H, Tanaka S, Barnard GF, Kitano S, Mori M (2001) Angiopoietin-2 is related to tumor angiogenesis in gastric carcinoma possible in vivo regulation via induction of proteases. Cancer Res 61(5):2145\u20132153","journal-title":"Cancer Res"},{"issue":"7","key":"1577_CR10","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/00000478-198210000-00007","volume":"6","author":"SA Fuhrman","year":"1982","unstructured":"Fuhrman SA, Lasky LC, Limas C (1982) Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 6(7):655\u2013664","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"1577_CR11","doi-asserted-by":"crossref","first-page":"135","DOI":"10.4110\/in.2011.11.3.135","volume":"11","author":"T-Y Ha","year":"2011","unstructured":"Ha T-Y (2011) MicroRNAs in human diseases: from cancer to cardiovascular disease. Immune Netw 11(3):135\u2013154","journal-title":"Immune Netw"},{"issue":"4","key":"1577_CR12","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/1246","volume":"19","author":"H Honda","year":"1998","unstructured":"Honda H, Oda H, Nakamoto T, Honda Z-I, Sakai R, Suzuki T, Saito T, Nakamura K, Nakao K, Ishikawa T (1998) Cardiovascular anomaly, impaired actin bundling and resistance to Src-induced transformation in mice lacking p130Cas. Nat Genet 19(4):361\u2013365","journal-title":"Nat Genet"},{"issue":"2","key":"1577_CR13","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s11912-009-0017-3","volume":"11","author":"B Hu","year":"2009","unstructured":"Hu B, Cheng S-Y (2009) Angiopoietin-2: development of inhibitors for cancer therapy. Curr Oncol Rep 11(2):111\u2013116","journal-title":"Curr Oncol Rep"},{"issue":"4","key":"1577_CR14","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrn2804","volume":"11","author":"M Inui","year":"2010","unstructured":"Inui M, Martello G, Piccolo S (2010) MicroRNA control of signal transduction. Nat Rev Mol Cell Bio 11(4):252\u2013263","journal-title":"Nat Rev Mol Cell Bio"},{"issue":"18","key":"1577_CR15","doi-asserted-by":"crossref","first-page":"7198","DOI":"10.1158\/0008-5472.CAN-09-0795","volume":"69","author":"E Izumchenko","year":"2009","unstructured":"Izumchenko E, Singh MK, Plotnikova OV, Tikhmyanova N, Little JL, Serebriiskii IG, Seo S, Kurokawa M, Egleston BL, Klein-Szanto A (2009) NEDD9 promotes oncogenic signaling in mammary tumor development. Cancer Res 69(18):7198\u20137206","journal-title":"Cancer Res"},{"issue":"7","key":"1577_CR16","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.cell.2006.06.008","volume":"125","author":"M Kim","year":"2006","unstructured":"Kim M, Gans JD, Nogueira C, Wang A, Paik J-H, Feng B, Brennan C, Hahn WC, Cordon-Cardo C, Wagner SN (2006) Comparative oncogenomics identifies NEDD9 as a melanoma metastasis gene. Cell 125(7):1269\u20131281","journal-title":"Cell"},{"issue":"5543","key":"1577_CR17","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1126\/science.1064921","volume":"294","author":"M Lagos-Quintana","year":"2001","unstructured":"Lagos-Quintana M, Rauhut R, Lendeckel W, Tuschl T (2001) Identification of novel genes coding for small expressed RNAs. Science 294(5543):853\u2013858","journal-title":"Science"},{"issue":"2","key":"1577_CR18","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nprot.2007.30","volume":"2","author":"C\u2013C Liang","year":"2007","unstructured":"Liang C\u2013C, Park AY, Guan J-L (2007) In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc 2(2):329\u2013333","journal-title":"Nat Protoc"},{"issue":"12","key":"1577_CR19","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1038\/sj.onc.1209199","volume":"25","author":"M Natarajan","year":"2005","unstructured":"Natarajan M, Stewart J, Golemis EA, Pugacheva E, Alexandropoulos K, Cox BD, Wang W, Grammer J, Gladson C (2005) HEF1 is a necessary and specific downstream effector of FAK that promotes the migration of glioblastoma cells. Oncogene 25(12):1721\u20131732","journal-title":"Oncogene"},{"key":"1577_CR20","doi-asserted-by":"crossref","unstructured":"Naumnik W, Naumnik B, Niewiarowska K, Ossolinska M, Chyczewska E (2013) Angiogenic axis angiopoietin-1 and angiopoietin-2\/tie-2 in non-small cell lung cancer: a bronchoalveolar lavage and serum study. Neurobiol Respir Spring 341\u2013348","DOI":"10.1007\/978-94-007-6627-3_46"},{"issue":"2","key":"1577_CR21","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.canlet.2013.03.003","volume":"335","author":"JH Noh","year":"2013","unstructured":"Noh JH, Chang YG, Kim MG, Jung KH, Kim JK, Bae HJ, Eun JW, Shen Q, Kim S-J, Kwon SH (2013) miR-145 functions as a tumor suppressor by directly targeting histone deacetylase 2 in liver cancer. Cancer Lett 335(2):455\u2013462","journal-title":"Cancer Lett"},{"issue":"5","key":"1577_CR22","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.ccr.2004.09.030","volume":"6","author":"J Oliner","year":"2004","unstructured":"Oliner J, Min H, Leal J, Yu D, Rao S, You E, Tang X, Kim H, Meyer S, Han SJ (2004) Suppression of angiogenesis and tumor growth by selective inhibition of angiopoietin-2. Cancer Cell 6(5):507\u2013516","journal-title":"Cancer Cell"},{"key":"1577_CR23","doi-asserted-by":"crossref","first-page":"782381","DOI":"10.1155\/2008\/782381","volume":"2008","author":"D Pascual","year":"2008","unstructured":"Pascual D, Borque A (2008) Epidemiology of kidney cancer. Adv Urol 2008:782381","journal-title":"Adv Urol"},{"issue":"1","key":"1577_CR24","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s13277-012-0573-2","volume":"34","author":"M Redova","year":"2012","unstructured":"Redova M, Poprach A, Besse A, Iliev R, Nekvindova J, Lakomy R, Radova L, Svoboda M, Dolezel J, Vyzula R, Slaby O (2012) MiR-210 expression in tumor tissue and in vitro effects of its silencing in renal cell carcinoma. Tumor Biol 34(1):481\u2013491. doi: 10.1007\/s13277-012-0573-2","journal-title":"Tumor Biol"},{"issue":"1","key":"1577_CR25","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00280-009-0983-z","volume":"64","author":"DJ Reeves","year":"2009","unstructured":"Reeves DJ, Liu CY (2009) Treatment of metastatic renal cell carcinoma. Cancer Chemoth Pharm 64(1):11\u201325","journal-title":"Cancer Chemoth Pharm"},{"issue":"9669","key":"1577_CR26","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S0140-6736(09)60229-4","volume":"373","author":"BI Rini","year":"2009","unstructured":"Rini BI, Campbell SC, Escudier B (2009) Renal cell carcinoma. Lancet 373(9669):1119\u20131132","journal-title":"Lancet"},{"issue":"7","key":"1577_CR27","doi-asserted-by":"crossref","first-page":"723","DOI":"10.18632\/oncotarget.547","volume":"3","author":"MC Speranza","year":"2012","unstructured":"Speranza MC, Frattini V, Pisati F, Kapetis D, Porrati P, Eoli M, Pellegatta S, Finocchiaro G (2012) NEDD9, a novel target of miR-145, increases the invasiveness of glioblastoma. Oncotarget 3(7):723","journal-title":"Oncotarget"},{"issue":"9","key":"1577_CR28","doi-asserted-by":"crossref","first-page":"a006550","DOI":"10.1101\/cshperspect.a006650","volume":"2","author":"G Thurston","year":"2012","unstructured":"Thurston G, Daly C (2012) The complex role of angiopoietin-2 in the angiopoietin\u2013tie signaling pathway. Cold Spring Harb Perspect Med 2(9):a006550","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"2","key":"1577_CR29","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/sj.bjc.6605742","volume":"103","author":"M Zaman","year":"2010","unstructured":"Zaman M, Chen Y, Deng G, Shahryari V, Suh S, Saini S, Majid S, Liu J, Khatri G, Tanaka Y (2010) The functional significance of microRNA-145 in prostate cancer. Br J Cancer 103(2):256\u2013264","journal-title":"Br J Cancer"},{"issue":"11","key":"1577_CR30","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1093\/abbs\/gmr080","volume":"43","author":"L Zhao","year":"2011","unstructured":"Zhao L, Chen X, Cao Y (2011) New role of microRNA: carcinogenesis and clinical application in cancer. Acta Biochim Biophys Sin 43(11):831\u2013839","journal-title":"Acta Biochim Biophys Sin"},{"issue":"12","key":"1577_CR31","doi-asserted-by":"crossref","first-page":"e15224","DOI":"10.1371\/journal.pone.0015224","volume":"5","author":"L Zhou","year":"2010","unstructured":"Zhou L, Chen J, Li Z, Li X, Hu X, Huang Y, Zhao X, Liang C, Wang Y, Sun L (2010) Integrated profiling of microRNAs and mRNAs: microRNAs located on Xq27. 3 associate with clear cell renal cell carcinoma. PLoS ONE 5(12):e15224","journal-title":"PLoS ONE"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-013-1577-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00432-013-1577-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-013-1577-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,5]],"date-time":"2019-08-05T14:41:54Z","timestamp":1565016114000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00432-013-1577-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,3]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["1577"],"URL":"https:\/\/doi.org\/10.1007\/s00432-013-1577-z","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,3]]}}}